We are live on
!
Find out more
ZEAL
Zealand Pharma A/S American Depositary Shares
ZEAL
ZEAL
Delisted
ZEAL was delisted on the 29th of September, 2022.
14 hedge funds and large institutions have $63.4M invested in Zealand Pharma A/S American Depositary Shares in 2020 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
6% more capital invested
Capital invested by funds: $60.1M → $63.4M (+$3.33M)
13% less funds holding
Funds holding: 16 → 14 (-2)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Holders
14
Holders Change
-2
Holders Change %
-12.5%
% of All Funds
0.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
3
Reduced
4
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$181K |
| 2 |
JP Morgan Chase
New York
|
+$26.4K |
| 3 |
Morgan Stanley
New York
|
+$12.9K |
Top Sellers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.33M |
| 2 |
Jane Street
New York
|
-$361K |
| 3 |
Rockefeller Capital Management
New York
|
-$175K |
| 4 |
Renaissance Technologies
New York
|
-$101K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$1.34K |
